Journal of Neurology Research, ISSN 1923-2845 print, 1923-2853 online, Open Access |
Article copyright, the authors; Journal compilation copyright, J Neurol Res and Elmer Press Inc |
Journal website http://www.neurores.org |
Original Article
Volume 4, Number 4, August 2014, pages 101-109
The Assessment of Basic Features of Electroencephalography in Metabolic Encephalopathies
Figures
Tables
Diagnostic subgroups | Woman | Man | Age |
---|---|---|---|
Data are shown as n (%) and median (minimum-maximum). | |||
Hyponatremia (n = 80) | 44 (11.4) | 36 (11.8) | 68 (21 - 77) |
Hypoxic (n = 73) | 24 (7.8) | 49 (16) | 66 (30 - 76) |
Renal failure (n = 44) | 17 (5.6) | 27 (8.8) | 58 (23 - 69) |
Hepatic insufficiency (n = 36) | 16 (5.2) | 20 (6.5) | 56 (19 - 67) |
Diabetes mellitus (n = 25) | 14 (4.6) | 11 (3.6) | 67 (20 - 80) |
Endocrinopathy (n = 27) | 20 (6.5) | 7 (2.3) | 54 (19 - 66) |
Hypernatremia (n = 21) | 10 (3.3) | 11 (3.6) | 69 (26 - 88) |
Diagnostic subgroups | Normal | Confused | Lethargic | Stupor | Coma |
---|---|---|---|---|---|
Data are shown as n (%). | |||||
Hyponatremia (n = 80) | 8 (2.6) | 22 (7.2) | 35 (11.4) | 12 (3.9) | 3 (1) |
Hypoxic (n = 73) | 0 (0) | 31 (10.1) | 20 (6.5) | 11 (3.6) | 11 (3.6) |
Renal failure (n = 44) | 14 (4.6) | 13 (4.2) | 9 (2.9) | 6 (2) | 2 (0.7) |
Hepatic insufficiency (n = 36) | 0 (0) | 3 (1) | 3 (1) | 16 (5.2) | 14 (4.6) |
Diabetes mellitus (n = 25) | 4 (1.3) | 11 (3.6) | 4 (1.3) | 2 (0.7) | 4 (1.3) |
Endocrinopathy (n = 27) | 4 (1.3) | 10 (3.3) | 4 (1.3) | 5 (1.6) | 4 (1.3) |
Hypernatremia (n = 21) | 0 (0) | 10 (3.3) | 5 (1.6) | 4 (1.3) | 2 (0.7) |
Diagnostic subgroups | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Stage 5 | Stage 6 |
---|---|---|---|---|---|---|
Data are shown as n (%). | ||||||
Hyponatremia (n = 80) | 6 (2) | 11 (3.6) | 31 (10.1) | 10 (3.3) | 3 (1) | 1 (0.3) |
Hypoxic (n = 73) | 5 (1.6) | 23 (7.5) | 13 (4.2) | 9 (2.9) | 4 (1.3) | 4 (1.3) |
Renal failure (n = 44) | 5 (1.6) | 20 (6.5) | 10 (3.3) | 8 (2.6) | 1 (0.3) | 0 (0) |
Hepatic insufficiency (n = 36) | 0 (0) | 1 (0.3) | 4 (1.3) | 20 (6.5) | 5 (1.6) | 6 (2) |
Diabetes mellitus (n = 25) | 0 (0) | 24 (7.8) | 0 (0) | 3 (1) | 0 (0) | 0 (0) |
Endocrinopathy (n = 27) | 0 (0) | 10 (3.3) | 3 (1) | 6 (2) | 2 (0.7) | 0 (0) |
Hypernatremia (n = 21) | 0 (0) | 10 (3.3) | 4 (1.3) | 6 (2) | 1 (0.3) | 0 (0) |
Diagnostic subgroups | Alpha reduction | Generalizedasynchronousslow waveactivity | Focal slowactivity | Trifazik wave | Burst-suppressionpattern | Fokal yada Jen. Keskin |
---|---|---|---|---|---|---|
Data are shown as n (%). | ||||||
Hyponatremia (n = 80) | 24 (7.8) | 32 (10.5) | 14 (4.6) | 1 (0.3) | 0 | 1 (0.3) |
Hypoxic (n = 73) | 33 (10.7) | 30 (9.8) | 6 (2) | 1 (0.3) | 3 (1) | 0 (0) |
Renal failure (n = 44) | 26 (8.5) | 16 (5.2) | 2 (0.7) | 0 (0) | 0 | 0 (0) |
Hepatic insufficiency (n = 36) | 5 (1.6) | 9 (2.9) | 3 (1) | 16 (5.2) | 0 | 3 (1) |
Diabetes mellitus(n = 25) | 0 (0) | 9 (2.9) | 6 (2) | 0 (0) | 0 | 1 (0.3) |
Endocrinopathy (n = 27) | 3 (1) | 15 (4.9) | 0 (0) | 1 (0.3) | 0 | 1 (0.3) |
Hypernatremia (n = 21) | 1 (0.3) | 10 (3.3) | 6 (2) | 1 (0.3) | 0 | 2 (0.7) |
Prognosis | Alpha reduction | Generalized asynchronous slow wave activity | Focal slow activity | Trifazik wave | Burst-suppressionpattern | Fokal yada Jen. Keskin |
---|---|---|---|---|---|---|
Data are shown as n (%). | ||||||
Düzelme/improvement | 92 (30) | 120 (39.2) | 36 (11.8) | 7 (2.3) | 0 | 7 (2.3) |
Exitus/exitus | 0 (0) | 1 (0.3) | 1 (0.3) | 6 (2 ) | 3 (1) | 1 (0.39) |
Prognosis | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Stage 5 | Stage 6 |
---|---|---|---|---|---|---|
Data are shown as n (%). | ||||||
Improvement | 16 (5.2) | 99 (32.4) | 64 (20.9) | 60 (19.6) | 11 (3.6) | 7 (2.3) |
Exitus | 0 (0) | 0 (0) | 1 (0.3) | 2 (0.7) | 5 (1.6) | 4 (1.3) |